Quarter 1 of 2017 is now officially int he books! Here we go, the music starts, the sun is brighter and I am feeling better/more rested each day. What else does this mean for, more specifically, US dividend income investors? The biggest month worth of paydays has finished and I can only hope the community feels the same. Did we set records? Did we reach expectations or did we learn something that we can create growth from? Time will tell when we are able to review all of the articles being released, but I am very pleased with how March ended from a dividend income stand point. Let’s dive into the results!
This month, I was back at it again and had some extra capital to deploy with a free trade credit staring my account in the face. So of course I was going to use this as an opportunity to continue building my position in T.Rowe Price Group (TROW) that I started in 2016. What’s funny is I wrote my last T.Rowe Price purchase article on 2/28/16, so almost a year ago exactly! One year later, I was faced with similar facts and made a similar decision. Time to see why I added to my stake!
I’ve been getting excite to write this post ever since I published my November 2016 dividend income summary. Why? Because December is the BEST DIVIDEND INCOME MONTH OF THE YEAR! Not only do we receive dividends from the majority of companies in our portfolio, but we also receive distributions from our mutual funds. More often than not, the capital gains distributions cause you to fall out of your seat as the number never seems to disappoint, especially when you have been contributing to your 401k throughout the year. Now that it is officially 2017, time for me to perform my final dividend income summary of 2016! Let’s see my December dividend income figures!
I’m starting with a disclaimer here. We could debate for hours the pros and cons of a Roth IRA; Heck, Lanny has written about both sides of the Roth vs. Traditional argument already…first about maximizing your Roth IRA contributions for 10 years and then writing about his plan to use a Traditional IRA going forward during the summer. What am I proving here? There is not a one size fits all approach and using a Roth or a Traditional account may (and should) change as your financial situation changes. This last week I experienced one of the downsides of a Roth IRA and I wanted to share it with all of you.
I couldn’t sit on the sidelines too long. After a strong month of purchased in January, which saw me add to my current stakes in ADM and CZNC, I wanted to keep the momentum rolling. At the end of my January dividend income article, I mentioned that I purchased a stock but haven’t disclosed the purchase yet to the community. Well, that is about to change. Last week I unloaded some capital and purchased a stake in Pfizer (PFE). Let’s see why!
Well, I couldn’t stay on the sidelines too long in 2016. I am AMPED and ready to start the year off strong after setting my goals and realizing that I have some serious work to do. One of the stocks I already own has been trading at a discount of late and let me tell you, I just couldn’t hold off any longer. Let’s dive right in and see which company won the honor of being my first stock purchased in 2016 (If the title hasn’t given it away already).
In his last purchase article, Lanny alluded to the fact that I may have purchased the same stock as his. Well, Lanny was right and great minds think alike. We have been talking about this purchase for several weeks and we finally just decided to buy it! While my rationale may have been slightly different than Lanny’s, here is why I added to my stake in Norwood Financial (NWFL).